URLC10, VEGFR1 and VEGFR2

BIOLOGICAL3 trials

Sponsors

Tokyo University

Conditions

Esophageal CancerGastric CancerNon Small Cell Lung Cancer

Phase 1

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Tokyo UniversityNon Small Cell Lung Cancer

Start: 2008-05-31End: 2009-04-30Target: 14Updated: 2008-05-14

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

CompletedNCT00681421

Tokyo UniversityEsophageal Cancer

Start: 2008-05-31End: 2009-04-30Target: 14Updated: 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

CompletedNCT00681252

Tokyo UniversityGastric Cancer

Start: 2008-05-31End: 2009-04-30Target: 14Updated: 2009-11-19